Autopsy report · NCT06404749
Fungal Fiber for Gut Health
Cause of deathFunding or business, also drug or device supply
“The sponsor company was dissolved, resulting in insufficient funding to continue production of the investigational dietary supplement.”
Life of this trial
- Ran for about 8 months before it stopped.
- 8 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Future Biome SA
- Sponsor type
- Industry
- Conditions
- Mild Gastrointestinal Symptoms in Healthy Adults; Low-grade Chronic Inflammation; Stress; Gut Health; Gut Permeability; Gut Microbiome
- Interventions
- fungal fiber; inulin
- Participants
- 8
- Sites
- 1
- Countries
- Argentina
Trials that died the same way
- Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma
“The sponsor decided to terminate the study due to financial issues following an FDA request for a partial clinical hold.” - Use Muscadine Wine Nutraceuticals to Improve Brain Health, Cognition, and Mental Health
“Funding for this study was discontinued by the sponsor after the first year.” - A Dose-escalation and Safety & Efficacy Study of AXO-AAV-GM2 in Tay-Sachs or Sandhoff Disease
“Sponsor withdrew from the study and there was a lack of funding to complete stage 2 of the designed study.” - Intravenous Ketamine Effects on Functional Neuroanatomy
“Sponsor is no longer interested in funding the study” - Safety Study of the VEGA UV-A System to Treat Keratoconus
“The sponsor terminated the study prior to data analysis for financial reasons.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.